Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
51,691,134
-
Shares change
-
+3,657,363
-
Total reported value, excl. options
-
$1,176,484,498
-
Value change
-
+$87,809,919
-
Put/Call ratio
-
113%
-
Number of buys
-
72
-
Number of sells
-
33
-
Price
-
$22.76
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q4 2019
As of 31 Dec 2019 ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) had 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,691,134 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and BOXER CAPITAL, LLC.
This table shows 116 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.